东亚药业：12月25日召开董事会会议

Group 1 - The core viewpoint of the news is that Dongya Pharmaceutical has announced its board meeting and provided details about its revenue composition for 2024 [1][2] - Dongya Pharmaceutical's market capitalization is reported to be 2.1 billion yuan [2] Group 2 - The company's revenue composition for the year 2024 indicates that the pharmaceutical and chemical sector accounts for 99.19% of its total revenue, while other businesses contribute only 0.81% [1]